Walid Fakhouri

The impact of disease severity and duration on cost, early retirement and ability to work in rheumatoid arthritis in Europe: an economic modelling study

James Galloway, Jean-Philippe Capron, Francesco De Leonardis et al. · Rheumatology Advances in Practice · 2020 · 30 citations · Full text

Long-term clinical, functional, and cost outcomes for early rheumatoid arthritis patients who did or did not achieve early remission in a real-world treat-to-target strategy

Peter M. ten Klooster, Martijn A. H. Oude Voshaar, Walid Fakhouri et al. · Clinical Rheumatology · 2019 · 26 citations · Full text

Radiographic progression can still occur in individual patients with low or moderate disease activity in the current treat-to-target paradigm: real-world data from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry

Peter M. ten Klooster, Letty G. A. Versteeg, Martijn A. H. Oude Voshaar et al. · Arthritis Research & Therapy · 2019 · 26 citations · Full text

Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: A multinational real-world cohort analysis

Cynthia Yang, Ross D. Williams, Joel N. Swerdel et al. · Seminars in Arthritis and Rheumatism · 2022 · 18 citations · Full text

<p>Cost-Effectiveness of a JAK1/JAK2 Inhibitor vs a Biologic Disease-Modifying Antirheumatic Drug (bDMARD) in a Treat-to-Target Strategy for Rheumatoid Arthritis</p>

Celine Johanna van de Laar, Martijn A. H. Oude Voshaar, Walid Fakhouri et al. · ClinicoEconomics and Outcomes Research · 2020 · 16 citations · Full text